Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Thomas H"'
Autor:
Elsayed Z. Soliman, Lynne E. Wagenknecht, Gerardo Heiss, Lin Y. Chen, Thomas H. Mosley, Eric A. Whitsel, Lisa M. Wruck, Alvaro Alonso, Laura R. Loehr, Anna K. Poon, David Couper
Publikováno v:
Am Heart J
Background A lower prevalence of atrial fibrillation (AF), but paradoxically higher burden of cardiovascular disease risk factors, has been observed among African Americans compared to Whites in studies of AF identified by mostly 12-lead electrocardi
Autor:
Kunal P. Verma, Thomas H Marwick, Carla Duarte, Peter Meikle, Mike Inouye, Melinda J. Carrington
Publikováno v:
American heart journal. 248
The traditional primary prevention paradigm for coronary artery disease (CAD) centers on population-based algorithms to classify individual risk. However, this approach often misclassifies individuals and leaves many in the 'intermediate' category, f
Autor:
David L. Prior, Jim Codde, Max Bulsara, Gregory M. Scalia, David S. Celermajer, David Playford, Marcus Ilton, Eli Gabbay, Geoff Strange, Thomas H. Marwick, Simon Stewart
Publikováno v:
American Heart Journal. 204:186-189
The National Echocardiography Database Australia (NEDA) is a new echocardiography database collecting digital measurements on both a retrospective and prospective basis. To date, echocardiographic data from 435,133 individuals (aged 61.6 ± 17.9 year
Publikováno v:
American heart journal. 231
Background Combined catheter ablation (CA) and left atrial appendage closure (LAAC) have been proposed for management of symptomatic atrial fibrillation (AF) in patients with high stroke and bleeding risk. We assessed the cost-effectiveness of combin
Autor:
Kristyn Whitmore, Geoffrey Mitchell, Andrew Tonkin, Amanda L. Neil, Stephen J. Nicholls, Tony Stanton, Thomas H. Marwick, Catherine M Jones, Gerald F. Watts, Christopher L. Blizzard
Publikováno v:
American Heart Journal. 199:22-30
The lifetime risk of coronary artery disease (CAD) is doubled in people with a family history of premature disease, yet this risk is not captured in most 5- or 10-year risk assessment algorithms. Coronary artery calcium scoring (CCS) is a marker of s
Autor:
Horst Sievert, Thomas H. Marwick, N. Mehta, Janusz Lipiecki, Ian T. Meredith, David M. Kaye, Brian Haluska, Steven L. Goldberg, Tomasz Siminiak
Publikováno v:
American heart journal. 188
The Carillon Mitral Contour System has been studied in 3 nonrandomized trials in patients with symptomatic congestive heart failure and functional mitral regurgitation. The REDUCE FMR study is a uniquely designed, double-blind trial evaluating the im
Autor:
Manuel C Cerqueira, Sinziana Seicean, Thomas H. Marwick, Rory Hachamovitch, Kazuaki Negishi, Wael A. Jaber, Nael Aldweib
Publikováno v:
American Heart Journal. 166:581-588
Appropriate use criteria (AUC) for stress single-photon emission computed tomography (SPECT) are only one step in appropriate use of imaging. Other steps include pretest clinical risk evaluation and optimal management responses. We sought to understa
Publikováno v:
American Heart Journal. 163:761-767
Background Noninvasive estimates of central blood pressure (BP) predict cardiovascular morbidity and mortality independent of brachial BP. However, there are limited data on the usefulness of central BP in clinical practice. This study aims to test t
Autor:
Steven E. Nissen, David Y. Graham, Henry Krum, Neville D. Yeomans, A. Michael Lincoff, Thomas F. Lüscher, Daniel H. Solomon, Lisa Wisniewski, Peter Libby, Kathy Wolski, M. Elaine Husni, Matthew C. Becker, Frank Ruschitzka, Thomas H. Wang, Alice M. Mascette, Jeffrey S. Borer
Publikováno v:
American Heart Journal. 157:606-612
Background Pain management in patients with osteoarthritis or rheumatoid arthritis often requires long-term use of nonsteroidal antiinflammatory drugs (NSAIDs). However, the relative cardiovascular safety of these therapies remains uncertain. Methods
Publikováno v:
American Heart Journal. 157:784-790
Background: Although guidelines recommend the use of beta-adrenoceptor blocking drugs to reduce cardiac events (CEs) after major noncardiac surgery, trial results have varied between showing benefit, ineffectiveness, and harm. We sought whether optim